9.14BMarket Cap
LossP/E TTM
TXG Balance Sheet
You can check out the annual or quarterly balance sheets of 10X Genomics Inc here to evaluate the financial health, analyze fundamentals, and calculate key ratios for liquidity, leverage, and return on equity.
FAQs
Which balance sheet metrics matter most when analyzing TXG stock?
Important metrics include cash and short-term investments, total assets, current assets, total liabilities, current liabilities, long-term debt, shareholders' equity, retained earnings, inventory, receivables, working capital, current ratio, quick ratio, debt-to-equity ratio, and return on equity. Investors usually review these together rather than relying on one number.
What is the difference between assets, liabilities, and shareholders' equity?
Assets are resources the company owns or controls, such as cash, receivables, inventory, investments, and property. Liabilities are obligations the company owes, such as accounts payable, debt, leases, and taxes. Shareholders' equity is the residual value after liabilities are subtracted from assets.
What is the difference between current and non-current items?
Current assets and current liabilities are generally expected to be converted, used, paid, or settled within one year or one operating cycle. Non-current assets and non-current liabilities are longer-term items, such as property, long-term investments, deferred tax assets, long-term debt, and lease obligations.
How Much Cash Does 10X Genomics Inc Have?
In its most recent quarterly, 10X Genomics Inc had 502.51M in cash and cash equivalents.
How Much Are 10X Genomics Inc's Total Liabilities?
10X Genomics Inc reported 245.04M in total liabilities as of the latest reported quarter, including 153.45M in current liabilities and 91.58M in non-current liabilities.
What Are 10X Genomics Inc's Total Assets?
As of the latest reported quarter, 10X Genomics Inc's total assets were 1.04B, consisting of 684.45M in current assets and 356.91M in non-current assets.
How Much Shareholders' Equity Does 10X Genomics Inc Have?
10X Genomics Inc reported 796.33M in total shareholders' equity as of the latest reported quarter.